QUEBEC CITY, May 16, 2012 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ)   (the "Company") announced today that it has received a notice from The NASDAQ Stock Market indicating

All amounts are in U.S.

NEW YORK, May 7, 2012 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that the Company and Aeterna Zentaris Inc.

Aeterna Zentaris to continue ongoing Phase 3 trial in multiple myeloma QUEBEC CITY, May 7, 2012 /PRNewswire/ - Aeterna Zentaris Inc.

QUÉBEC CITY, May 3, 2012 /PRNewswire/ - Aeterna Zentaris Inc.